Good morning, everyone, and how are you today? We are doing just fine, thank you, especially now that relatively balmy temperatures have unexpectedly descended on the Pharmalot campus. Although we are not abandoning our motto — “To live is to complain” — we will not kvetch about a welcome shot of warmth. In fact, this calls for a celebratory cup of stimulation and, of course, you are invited to join us. While you do, you can also peruse some items of interest to get the day started. Hope all goes well and, as always, do keep in touch …

The Senate Finance Committee invited seven major drug makers to testify before a committee hearing on drug pricing on Feb. 26, the second in a series of hearings examining prescription drug costs, STAT notes. The companies invited include AbbVie (ABBV), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ), Merck (MRK), Pfizer (PFE), and Sanofi (SNY). Several of these companies initially declined a committee request to testify at the previous hearing held on Jan. 29.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy